{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:53:11Z","timestamp":1791337991243,"version":"4.3.1"},"reference-count":38,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8,1]]},"DOI":"10.1210\/jc.2014-1258","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T14:18:15Z","timestamp":1398781095000},"page":"2763-2770","source":"Crossref","is-referenced-by-count":86,"title":["Abiraterone Acetate to Lower Androgens in Women With Classic 21-Hydroxylase Deficiency"],"prefix":"10.1210","volume":"99","author":[{"given":"Richard J.","family":"Auchus","sequence":"first","affiliation":[{"name":"Division of Metabolism, Diabetes, and Endocrinology (R.J.A., E.O.B., G.D.H., C.R., D.M.), University of Michigan, Ann Arbor, Michigan 48109"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth O.","family":"Buschur","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Diabetes, and Endocrinology (R.J.A., E.O.B., G.D.H., C.R., D.M.), University of Michigan, Ann Arbor, Michigan 48109"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Y.","family":"Chang","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Metabolism, Diabetes, and Nutrition (A.Y.C.), Mayo Clinic, Rochester, Minnesota 55905"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary D.","family":"Hammer","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Diabetes, and Endocrinology (R.J.A., E.O.B., G.D.H., C.R., D.M.), University of Michigan, Ann Arbor, Michigan 48109"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Ramm","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Diabetes, and Endocrinology (R.J.A., E.O.B., G.D.H., C.R., D.M.), University of Michigan, Ann Arbor, Michigan 48109"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Madrigal","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Diabetes, and Endocrinology (R.J.A., E.O.B., G.D.H., C.R., D.M.), University of Michigan, Ann Arbor, Michigan 48109"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Wang","sequence":"additional","affiliation":[{"name":"Janssen Research and Development (G.W., M.G., X.S.X., J.J.), Raritan, New Jersey 08869"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Janssen Research and Development (G.W., M.G., X.S.X., J.J.), Raritan, New Jersey 08869"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu Steven","family":"Xu","sequence":"additional","affiliation":[{"name":"Janssen Research and Development (G.W., M.G., X.S.X., J.J.), Raritan, New Jersey 08869"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W.","family":"Smit","sequence":"additional","affiliation":[{"name":"Janssen Research and Development (J.W.S.), 2340 Beerse, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Jiao","sequence":"additional","affiliation":[{"name":"Janssen Research and Development (G.W., M.G., X.S.X., J.J.), Raritan, New Jersey 08869"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret K.","family":"Yu","sequence":"additional","affiliation":[{"name":"Janssen Research and Development (M.K.Y.), Los Angeles, California 90024"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113320797500_B1","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"White","year":"2000","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113320797500_B2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1056\/NEJMra021561","article-title":"Congenital adrenal hyperplasia","volume":"349","author":"Speiser","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113320797500_B3","first-page":"17","article-title":"Evidence for frequent gene conversions in the steroid 21-hydroxylase (P-450c21) gene: implications for steroid 21-hydroxylase deficiency","volume":"42","author":"Higashi","year":"1988","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t2019041113320797500_B4","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1210\/jcem-62-5-995","article-title":"Gene conversion in salt-losing congenital adrenal hyperplasia with absent complement C4B protein","volume":"62","author":"Donohoue","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113320797500_B5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jcem-68-3-592","article-title":"Gene conversions and rearrangements cause discordance between inheritance of forms of 21-hydroxylase deficiency and HLA types","volume":"68","author":"Morel","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113320797500_B6","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1073\/pnas.82.4.1089","article-title":"Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man","volume":"82","author":"White","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113320797500_B7","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1073\/pnas.83.9.2841","article-title":"Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and genuine gene","volume":"83","author":"Higashi","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113320797500_B8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1542\/peds.101.4.583","article-title":"Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia","volume":"101","author":"Therrell","year":"1998","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t2019041113320797500_B9","first-page":"650","article-title":"High frequency of nonclassical steroid 21-hydroxylase deficiency","volume":"37","author":"Speiser","year":"1985","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t2019041113320797500_B10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/BF02265290","article-title":"Genotype of Yupik Eskimos with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"88","author":"Speiser","year":"1992","journal-title":"Hum Genet"},{"key":"key\n\t\t\t\t2019041113320797500_B11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113320797500_B12","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"95","author":"Speiser","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113320797500_B13","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","author":"Arlt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113320797500_B14","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1210\/jc.2012-2102","article-title":"Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia","volume":"97","author":"Finkielstain","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113320797500_B15","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1210\/jc.2009-0942","article-title":"Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation","volume":"94","author":"Bonfig","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113320797500_B16","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1021\/jm00013a022","article-title":"Novel steroidal inhibitors of human cytochrome P45017\u03b1 (17\u03b1-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer","volume":"38","author":"Potter","year":"1995","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t2019041113320797500_B17","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","article-title":"Abiraterone and increased survival in metastatic prostate cancer","volume":"364","author":"de Bono","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113320797500_B18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1209096","article-title":"Abiraterone in metastatic prostate cancer without previous chemotherapy","volume":"368","author":"Ryan","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113320797500_B19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1210\/jc.2003-031021","article-title":"Two prevalent CYP17 mutations and genotype-phenotype correlations in 24 Brazilian patients with 17-hydroxylase deficiency","volume":"89","author":"Costa-Santos","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113320797500_B20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/B978-0-12-416006-4.00009-0","article-title":"Genetic deficiencies of cytochrome P450c17 (CYP17A1): combined 17-hydroxylase\/17,20-lyase and isolated 17,20-lyase deficiency","volume-title":"Genetic Steroid Disorders","author":"Auchus","year":"2014"},{"key":"key\n\t\t\t\t2019041113320797500_B21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1210\/jc.2011-2189","article-title":"Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer","volume":"97","author":"Attard","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113320797500_B22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2310\/JIM.0b013e3182408567","article-title":"Human steroid biosynthesis for the oncologist","volume":"60","author":"Auchus","year":"2012","journal-title":"J Invest Med"},{"key":"key\n\t\t\t\t2019041113320797500_B23","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1200\/JCO.2008.20.0642","article-title":"Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer","volume":"27","author":"Attard","year":"2009","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019041113320797500_B24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2265.2009.03636.x","article-title":"A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia","volume":"72","author":"Verma","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113320797500_B25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jsbmb.2010.04.010","article-title":"Gas chromatography\/mass spectrometry (GC\/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC\/MS\/MS)","volume":"121","author":"Krone","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key\n\t\t\t\t2019041113320797500_B26","doi-asserted-by":"crossref","first-page":"E2084","DOI":"10.1210\/jc.2012-2298","article-title":"Use of PET\/CT with cosyntropin stimulation to identify and localize adrenal rest tissue following adrenalectomy in a woman with congenital adrenal hyperplasia","volume":"97","author":"Crocker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113320797500_B27","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1210\/jc.2009-1929","article-title":"Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency","volume":"95","author":"Reisch","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113320797500_B28","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-2265.2011.04151.x","article-title":"High frequency of adrenal myelolipomas and testicular adrenal rest tumours in adult Norwegian patients with classical congenital adrenal hyperplasia because of 21-hydroxylase deficiency","volume":"75","author":"Nermoen","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113320797500_B29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1365-2265.2009.03563.x","article-title":"Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate","volume":"70","author":"Caster\u00e0s","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113320797500_B30","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1210\/edrv-3-4-396","article-title":"Extra-adrenal formation of a mineralocorticoid: Deoxycorticosterone and deoxycorticosterone sulfate biosynthesis and metabolism","volume":"3","author":"Casey","year":"1982","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t2019041113320797500_B31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1210\/jc.2008-1174","article-title":"Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency","volume":"94","author":"Gomes","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113320797500_B32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature10743","article-title":"Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001","volume":"482","author":"DeVore","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t2019041113320797500_B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2014.01.013","article-title":"A-Ring modified steroidal azoles retain similar potent and slowly reversible CYP17A1 inhibition as abiraterone","volume":"143C","author":"Garrido","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"key\n\t\t\t\t2019041113320797500_B34","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1210\/jc.2013-1440","article-title":"Approach to the patient: the adult with congenital adrenal hyperplasia","volume":"98","author":"Auchus","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113320797500_B35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0039-128X(99)00090-2","article-title":"Influence of oral dehydroepiandrosterone (DHEA) on urinary steroid metabolites in males and females","volume":"65","author":"Callies","year":"2000","journal-title":"Steroids"},{"key":"key\n\t\t\t\t2019041113320797500_B36","doi-asserted-by":"crossref","first-page":"E367","DOI":"10.1210\/jc.2011-1997","article-title":"Increased activation of the alternative \u201cbackdoor\u201d pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis","volume":"97","author":"Kamrath","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113320797500_B37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1210\/en.2002-220721","article-title":"5\u03b1-Androstane-3\u03b1,17\u03b2-diol is formed in tammar wallaby pouch young testes by a pathway involving 5\u03b1-pregnane-3\u03b1,17\u03b1-diol-20-one as a key intermediate","volume":"144","author":"Wilson","year":"2003","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113320797500_B38","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tem.2004.09.004","article-title":"The backdoor pathway to dihydrotestosterone","volume":"15","author":"Auchus","year":"2004","journal-title":"Trends Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/99\/8\/2763\/9049360\/jcem2763.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T00:16:02Z","timestamp":1565396162000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/99\/8\/2763\/2537872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2014-1258","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,1]]}}}